BDNF and CGRP interaction: Implications in migraine susceptibility

Cephalalgia

Volumn 30, Issue 11, 2010, Pages 1375-1382

  Lemos, Carolina ^a   Mendonça, Denisa ^a   Pereira Monteiro, José ^a,b   Barros, José ^b   Sequeiros, Jorge ^a   Alonso, Isabel ^a   Sousa, Alda ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

association; BDNF; CGRP; Migraine; pathophysiology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENDER; GENE FREQUENCY; GENE INTERACTION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79751474283     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410368443     Document Type: Article

References (47)

1. Kalfakis N., Panas M., Vassilopoulos D., Malliara-Loulakaki S. Migraine with aura: segregation analysis and heritability estimation. Headache 1996 ; 36: 320-322. (Pubitemid 26162557)
2. Devoto M., Lozito A., Staffa G., D'Alessandro R., Sacquegna T., Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia 1986 ; 6: 101-105.
3. Menken M., Munsat TL, Toole JF The global burden of disease study: implications for neurology. Arch Neurol 2000 ; 7: 418-420. (Pubitemid 30140537)
4. Mazaheri S., Hajilooi M., Rafiei A. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura. J Neurol 2006 ; 253: 1589-1593. (Pubitemid 46115441)
5. Xu MQ, St Clair D., Ott J., Feng GY, He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 2007 ; 91: 6-13.
6. Lipsky RH, Marini AM Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci 2007 ; 1122: 130-143. (Pubitemid 350249544)
7. Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ, McMahon SB Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci USA 1999 ; 96: 7714-7718. (Pubitemid 29328346)
8. Blandini F., Rinaldi L., Tassorelli C., et al. Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia 2006 ; 26: 136-142.
9. Mannion RJ, Costigan M., Decosterd I., et al. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc Natl Acad Sci USA 1999 ; 96: 9385-9390. (Pubitemid 29374764)
10. Pietrobon D. Migraine: new molecular mechanisms. Neuroscientist 2005 ; 11: 373-386. (Pubitemid 41040865)
11. Buldyrev I., Tanner NM, Hsieh HY, Dodd EG, Nguyen LT, Balkowiec A. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons. J Neurochem 2006 ; 99: 1338-1350. (Pubitemid 44730090)
12. Urbach A., Bruehl C., Witte OW Microarray-based long-term detection of genes differentially expressed after cortical spreading depression. Eur J Neurosci 2006 ; 24: 841-856. (Pubitemid 44232528)
13. Durham PL Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006 ; 46 (Suppl 1). 3-8.
14. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002 ; 22: 54-61. (Pubitemid 34626025)
15. Greco R., Tassorelli C., Sandrini G., Di Bella P., Buscone S., Nappi G. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia 2008 ; 28: 114-126.
16. Striessnig J. Pathophysiology of migraine headache: insight from pharmacology and genetics. Drug Discovery Today: Disease Mechanisms 2005 ; 2 (4). 453-462.
17. Benemei S., Nicoletti P., Capone JA, Geppetti P. Pain pharmacology in migraine: focus on CGRP and CGRP receptors. Neurol Sci 2007 ; 28 (Suppl 2). 89-93.
18. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993 ; 33: 48-56. (Pubitemid 23009909)
19. Goadsby PJ, Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990 ; 28: 183-187. (Pubitemid 20244522)
20. Tvedskov JF, Lipka K., Ashina M., Iversen HK, Schifter S., Olesen J. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 2005 ; 58: 561-568. (Pubitemid 41377219)
21. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 2004 ; 24: 611-622. (Pubitemid 39061250)
22. Marziniak M., Herzog AL, Mossner R., Sommer C. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine. J Neural Transm 2008 ; 115 (9). 1321-1325.
23. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8: 1-96.
24. International Headache Society. International Classification of Headache Disorders. 2nd edn. Cephalalgia 2004 ; 24 (Suppl 1). 1-160.
25. Miller SA, Dykes DD, Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 ; 16: 1215.
26. Barrett JC, Fry B., Maller J., Daly MJ Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 ; 21: 263-265. (Pubitemid 40202029)
27. Ritchie MD, Hahn LW, Roodi N., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001 ; 69: 138-147. (Pubitemid 32614026)
28. Moore JH Computational analysis of gene-gene interactions using multifactor dimensionality reduction. Expert Rev Mol Diagn 2004 ; 4: 795-803. (Pubitemid 39487584)
29. Moore JH, Gilbert JC, Tsai CT, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006 ; 241: 252-261. (Pubitemid 43993963)
30. Greene CS, Himmelstein DS, Nelson HH, et al. Enabling personal genomics with an explicit test of epistasis. Pac Symp Biocomput 327-336.
31. Pereira Monteiro JM, Maio R., Calheiros JM Overlap of migraine and tension-type headaches in a population-based study. In: Olesen J (ed.) Headache classification and epidemiology. Vol 4, New York: Raven Press, 1994, p. 103-106.
32. Pereira Monteiro JM, Barros JR Familial incidence of primary headaches in a general population. In: Olesen J, Bousser M-G (eds) Genetics of headache disorders. Vol 8, Philadelphia: Lippincott-Williams & Wilkins, 2000, p. 37-40.
33. Lin HY, Desmond R., Bridges Jr SL, Soong SJ Variable selection in logistic regression for detecting SNP-SNP interactions: the rheumatoid arthritis example. Eur J Hum Genet 2008 ; 16: 735-741. (Pubitemid 351753370)
34. Coffey CS, Hebert PR, Ritchie MD, et al. An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics 2004 ; 5: 49.
35. Ritchie MD, Hahn LW, Moore JH Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003 ; 24: 150-157. (Pubitemid 36158211)
36. Hemminki K., Forsti A., Bermejo JL The 'common disease-common variant' hypothesis and familial risks. PLoS ONE 2008 ; 3: e2504.
37. Reijmerink NE, Bottema RW, Kerkhof M., et al. TLRrelated pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 2010 ; 65: 199-207.
38. Pereira L., Prata MJ, Amorim A. Diversity of mtDNA lineages in Portugal: not a genetic edge of European variation. Ann Hum Genet 2000 ; 64: 491-506. (Pubitemid 32166502)
39. Pereira R., Fondevila M., Philips C., Amorim A., Carracedo A., Gusmao L. Genetic characterization of 52 autosomal SNPs in the Portuguese population. Genetics Supplement Series. Forensic Sci Int 2008 ; 1: 358-360.
40. Beleza S., Gusmao L., Lopes A., et al. Micro-phylogeographic and demographic history of Portuguese male lineages. Ann Hum Genet 2006 ; 70: 181-194.
41. Bird TD, Jarvik GP, Wood NW Genetic association studies: genes in search of diseases. Neurology 2001 ; 57: 1153-1154. (Pubitemid 32947369)
42. Recober A., Russo AF Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol 2009 ; 22: 241-246.
43. Storer RJ, Akerman S., Goadsby PJ Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004 ; 142: 1171-1181. (Pubitemid 39093014)
44. Mehrotra S., Gupta S., Chan KY, et al. Current and prospective pharmacological targets in relation to antimigraine action. Naunyn- Schmiedebergs' Arch Pharmacol 2008 ; 378: 371-394.
45. Recober A., Kuburas A., Zhang Z., Wemmie JA, Anderson MG, Russo AF Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci 2009 ; 29: 8798-8804.
46. Simonetti M., Giniatullin R., Fabbretti E. Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem 2008 ; 283: 18743-18752.
47. Angelucci F., Brene S., Mathe AA BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005 ; 10: 345-352.